Medical writing capacity pressure is fundamentally a talent development problem, not a technology problem, since hybrid ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...

In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure ...

Patients don’t experience primary endpoints, so trials that stop at biomarkers and rigid rating scales risk declaring success ...

Participant payment processes in clinical trials are evolving as sponsors and sites adopt automated technologies to improve payment speed, accuracy, transparency, and payment flexibility while ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.

Regulation is not preventing continuous decision readiness. Increasingly, it is defining the conditions under which it can be ...

Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.

Morgan Griffith (R-Va.) would make it easier for patients to join clinical trials and shorten the time it takes ...

Mats Sundgren, Ashley Deis, Annie E. Almazar, Mathew Bush, Jose Galvez, Kathleen Hurtado, Lee Andrews, Nausheen Saleem, Anna Patruno, and Richard Yeatman | Authors | Applied Clinical Trials is the ...

He opened by drawing a clear distinction between point solutions and embedded AI: when each function—protocol design, feasibility, monitoring, data review—uses AI in isolation, task efficiencies ...